Valsartan and Hydrocephalus - a phase IV clinical study of FDA data

Summary:

Hydrocephalus is reported as a side effect among people who take Valsartan (valsartan), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Selenium, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Hydrocephalus when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

What is Hydrocephalus?

Hydrocephalus (water on the brain) is found to be associated with 764 drugs and 1,367 conditions by eHealthMe. Check the latest studies of Hydrocephalus.

On Jul, 06, 2026

62,763 people reported to have side effects when taking Valsartan.
Among them, 19 people (0.03%) have Hydrocephalus.

Among these 19 people:

How long have people been on Valsartan when they have Hydrocephalus? *

What is the gender of people who have Hydrocephalus when taking Valsartan? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Hydrocephalus when taking Valsartan? *

What are other drugs people take besides Valsartan? *

What are other side effects people have besides Hydrocephalus? *

Insomnia (sleeplessness): 6 people, 31.58%
Breast Enlargement: 5 people, 26.32%
Disturbance In Attention: 5 people, 26.32%
Meningioma (a diverse set of tumours arising from the meninges): 5 people, 26.32%
Muscle Tightness: 5 people, 26.32%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 5 people, 26.32%
Occipital Neuralgia (a condition characterized by chronic pain in the upper neck): 5 people, 26.32%
Decreased Activity: 5 people, 26.32%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 26.32%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 5 people, 26.32%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 21.05%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
Constipation: 2 people, 10.53%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.26%
Pneumonia: 1 person, 5.26%
Mantle Cell Lymphoma Refractory (relapsed cancer of lymphocytes, a type of white blood cell): 1 person, 5.26%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.26%
Hypokalemia (low potassium): 1 person, 5.26%
Gout (uric acid crystals building up in the body): 1 person, 5.26%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Valsartan and have Hydrocephalus?

- Check whether Hydrocephalus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valsartan:

Valsartan (63,805 reports)

Hydrocephalus treatments and more:

Hydrocephalus (6,876 reports)

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hydrocephalus:

Hydrocephalus (764 drugs)

Browse all the conditions that are associated with Hydrocephalus:

Hydrocephalus (1,367 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.